118 related articles for article (PubMed ID: 19302265)
1. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses.
Zhang Y; Chen QB; Gao ZY; Xie WF
Aliment Pharmacol Ther; 2009 Jun; 29(11):1155-64. PubMed ID: 19302265
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Bai Y; Gao J; Zou DW; Li ZS
Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
[TBL] [Abstract][Full Text] [Related]
3. Can wire-guided cannulation reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis? A meta-analysis of randomized controlled trials.
Shao LM; Chen QY; Chen MY; Cai JT
J Gastroenterol Hepatol; 2009 Nov; 24(11):1710-5. PubMed ID: 20136957
[TBL] [Abstract][Full Text] [Related]
4. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
[TBL] [Abstract][Full Text] [Related]
6. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
[TBL] [Abstract][Full Text] [Related]
8. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
Foster E; Leung J
Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
[TBL] [Abstract][Full Text] [Related]
10. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Bai Y; Gao J; Shi X; Zou D; Li Z
Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
[TBL] [Abstract][Full Text] [Related]
12. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
14. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis.
Bang UC; Nøjgaard C; Andersen PK; Matzen P
Aliment Pharmacol Ther; 2009 May; 29(10):1078-85. PubMed ID: 19236312
[TBL] [Abstract][Full Text] [Related]
16. Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of randomized controlled trials.
Moretti A; Papi C; Aratari A; Festa V; Tanga M; Koch M; Capurso L
Dig Liver Dis; 2008 May; 40(5):379-85. PubMed ID: 18243826
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
Rudin D; Kiss A; Wetz RV; Sottile VM
J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
[TBL] [Abstract][Full Text] [Related]
18. Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials.
Petrov MS; van Santvoort HC; Besselink MG; van der Heijden GJ; van Erpecum KJ; Gooszen HG
Ann Surg; 2008 Feb; 247(2):250-7. PubMed ID: 18216529
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.
Andriulli A; Forlano R; Napolitano G; Conoscitore P; Caruso N; Pilotto A; Di Sebastiano PL; Leandro G
Digestion; 2007; 75(2-3):156-63. PubMed ID: 17684365
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
